Stephen Doster
-
Dean’s Faculty Fellows program recognizes Neuert, Ren
By Lorena Infante Lara, February 15, 2021 Assistant Professor of Biochemistry Yi Ren and Assistant Professor of Molecular Physiology and Biophysics Gregor Neuert have been recognized as School of Medicine Basic Sciences Dean’s Faculty Fellows. Established in 2020, the Dean’s Faculty Fellows program in Basic Sciences is designed to recognize… Read MoreFeb. 17, 2021
-
SARS-CoV-2 protein blocks an essential step in host gene expression, new discovery finds
by Marissa Shapiro Feb. 17, 2021, 9:00 AM Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens… Read MoreFeb. 17, 2021
-
Bruce Carter joins CMT Research Foundation scientific advisory board
by Marissa Shapiro Feb. 12, 2021, 9:00 AM Bruce Carter (Vanderbilt University) Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation. He joins… Read MoreFeb. 12, 2021
-
Discovery shows how to treat heart attacks; drug development underway
by Marissa Shapiro Feb. 11, 2021, 9:00 AM Vanderbilt researchers have identified the protein receptor in specialized heart cells that, when removed, preserves cardiac function after a heart attack. This discovery has significant implications for survival after a heart attack, with a promising therapeutic… Read MoreFeb. 11, 2021
-
Evotec begins Phase I clinical trial of chikungunya antibody discovered by James Crowe, MD and VUMC colleagues
A Vanderbilt University Medical Center licensee, Evotec SE, announced on January 28, 2020 that EVT894, a monoclonal antibody to treat and potentially prevent chikungunya virus infections, has entered clinical development. The Phase I, randomised, double-blind, single centre, single dose escalation study to evaluate the safety, pharmacokinetics, and immunogenicity of EVT894 vs… Read MoreFeb. 5, 2021
-
Gene network for leukemia factor
Feb. 4, 2021, 9:00 AM by Leigh MacMillan Transcription factors — proteins that regulate gene expression — play critical roles in cell fate decisions and are frequent targets of mutation in a variety of human cancers. Understanding how transcription factors contribute to disease requires the identification of their direct gene targets, but traditional methods are time-consuming… Read MoreFeb. 4, 2021
-
Trans-institutional collaboration receives $2 million BRAIN Initiative grant, developing brain organoids to map neurological development
Vivian Gama, assistant professor of cell and developmental biology, and Leon Bellan, associate professor of mechanical engineering and biomedical engineering, have won a $2.3 million, three-year grant from the National Institutes of Health Brain Research through Advancing Innovative Neurotechnologies Initiative. Vivian Gama Leon Bellan (Vanderbilt University) The researchers will be developing three-dimensional brain organoids and related tissue—miniaturized… Read MoreFeb. 1, 2021
-
Study’s findings may help eventually close the door on COVID-19
Jan. 28, 2021, 10:05 AM by Bill Snyder Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may be the Achilles’ heel of the coronavirus, a finding that may help close the door on COVID-19 and possibly head off future… Read MoreJan. 28, 2021
-
Vanderbilt joins Wellcome Leap global network dedicated to accelerating breakthroughs in human health
by Marissa Shapiro Jan. 28, 2021, 7:00 AM Vanderbilt University has joined the Leap Health Breakthrough Network, a global group of leading academic and research institutions committed to solving the world’s most serious health challenges—such as cancer and infectious diseases—at record speed. Wellcome Leap is… Read MoreJan. 28, 2021
-
A protein that can melt tumors discovered at Vanderbilt
by Marissa Shapiro Jan. 27, 2021, 9:00 AM For the second time, cancer researchers at Vanderbilt have discovered a protein that—when genetically manipulated to impede it from interacting with a gene responsible for cancer genesis—effectively melts tumors in days. The article, “MYC regulates ribosome… Read MoreJan. 28, 2021